Press release
Global Cyclosporine drugs Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027
Global Cyclosporine drugs Market is anticipated to showcase considerable growth during the forecast period (2020-2026). The new product launches with rising FDA approvals are a factor contributing to the growth of the global cyclosporine drugs market. Cyclosporine drug is an immunosuppressant class of drugs that is extracted from Tolypocladium fungus which prevents side effects on the immune system such as encephalomyelitis, graft diseases, allograft rejection, delayed hypersensitivity and experimental allergy. In addition, the cyclosporine drug is used in the treatment of a broad spectrum of diseases such as dry eye syndrome, rheumatoid arthritis, and psoriasis. Neoral and Sandimmune are the available drug formulations for the oral route, and Restasis is used for ocular delivery of cyclosporine.To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/cyclosporine-drugs-market
AbbVie Inc., Allergan PLC, Apotex Inc., Eon Labs, Mayne Pharma Group Ltd. McKesson Medical-Surgical Inc., Novartis Inc., Santen Inc., Sun Pharmaceuticals, Teva Pharmaceuticals, and so on are the key players operating in the global cyclosporine drugs market. These players are actively involved in adopting different growth strategies such as mergers and acquisitions, partnerships, collaboration, and strategic agreements among others to remain competitive in the market place. New product launches and investment in the R&D is the key strategy adopted by the players of the global cyclosporine drugs market to sustain their marketplace.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/cyclosporine-drugs-market
For instance, in March 2019, Breath Therapeutics Inc. had announced the launch of a Ph3 trial for the inhaled liposomal cyclosporine A therapy. In August 2018, Sun Pharmaceutical Industries Ltd. had received US FDA approval for CEQUA (cyclosporine ophthalmic solution) 0.09%. CEQUA is an aqueous solution used to increase tear production in patients suffering from keratoconjunctivitis sicca (dry eye). CEQUA provides the highest FDA-approved concentration of cyclosporine A (CsA) and is based on nanomicellar technology. The innovative nanomicellar formulation used in CEQUA allows the CsA molecule to overcome the solubility challenges involved in the treatment of the dry eyes by penetrating the eye’s aqueous layer and preventing the release of the active lipophilic molecule before the actual penetration.
In May 2018, Teva Canada Ltd, a subsidiary of Teva Pharmaceutical Industries Ltd., had launched Teva-Cyclosporine ophthalmic emulsion, 0.05% w/v, a Health Canada approved twice-daily eye drop solution and the first generic version of Restasis (cyclosporine) in Canada. Cyclosporine ophthalmic emulsion is produced for the treatment of moderate to moderately severe aqueous deficient dry eye syndrome having ocular staining, reduction in tear production, and fluctuating visual symptoms.
Cyclosporine Drugs Market Segmentation
By Indication
• Rheumatoid Arthritis
• Psoriasis
• Transplant Rejection Prophylaxis
• Dry Eye
• Autoimmune Myasthenia Gravis
• Other
By Route of Administration
• Oral
• Parenteral
Cyclosporine Drugs market – Segment by Region
North America
• The US
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
Company Profiles
• AbbVie Inc.
• Allergan PLC
• Apotex, Inc.
• Mayne Pharma Group Ltd.
• Mckesson Medical Surgical Inc.
• Novartis AG
• Otsuka Pharmaceutical Co. Ltd.
• Regenerx Biopharmaceuticals, Inc.
• Santen Pharmaceuticals Co. Ltd.
• Sun Pharmaceuticals Industries, Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceuticals Industries, Ltd.
• United Biotech Pvt. Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cyclosporine-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cyclosporine drugs Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027 here
News-ID: 2392600 • Views: …
More Releases from Orion Market Research

Terahertz Technology Market Set to Witness Significant Growth by 2032 | TOPTICA …
The Terahertz Technology Market was valued at approximately USD 1.09 billion in 2024 and is projected to reach USD 4.08 billion by 2032, reflecting a compound annual growth rate (CAGR) of 18.1% from 2025 to 2032.
Terahertz Technology Market Overview
Terahertz (THz) technology operates in the electromagnetic spectrum between microwave and infrared waves, encompassing frequencies from 0.1 to 10 THz. This technology is gaining prominence due to its non-ionizing radiation, enabling…

Specialty Tapes Market Set to Witness Significant Growth by 2032 | Avery Denniso …
The global Specialty Tapes Market was valued at approximately USD 55.39 billion in 2023 and is projected to reach USD 96.3 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.3% from 2024 to 2032.
Specialty Tapes Market Overview
The Specialty Tapes Market encompasses a diverse range of adhesive products tailored for specific applications across various industries. These tapes are characterized by their unique properties, such as high temperature…

Safety Helmets Market Set to Witness Significant Growth by 2033 | MSA Safety, Uv …
The global Safety Helmets Market was valued at approximately USD 5.01 billion in 2024, and it is expected to reach around USD 9.76 billion by 2033, growing at a *compound annual growth rate (CAGR) of about 7.7% from 2025 to 2033.
Safety Helmets Market Overview
The Safety Helmets Market is gaining momentum as industries like construction, manufacturing, mining, and infrastructure increasingly emphasize worker safety and regulatory compliance. Safety helmets-designed to protect against…

Sales Performance Management Market Gaining Momentum by 2033 | Xactly Corporatio …
The global Sales Performance Management market was valued at approximately USD 5.62 billion in 2024 and is projected to grow to about USD 18.22 billion by 2033, with a compound annual growth rate (CAGR) of approximately 13.27% between 2025 and 2033.
Sales Performance Management Market Overview
Sales Performance Management integrates tools and processes designed to boost sales productivity, optimize incentive structures, and align field sales efforts with business goals. Today's market is…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…